Prognostic Impact of Negative Serum (1,3)-β-D-glucan in Patients With Candidemia

Clin Infect Dis. 2020 Aug 14;71(4):1124-1126. doi: 10.1093/cid/ciz1051.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Adult
  • Candidemia* / diagnosis
  • Candidemia* / drug therapy
  • Glucans
  • Humans
  • Prognosis
  • Proteoglycans
  • Tertiary Care Centers
  • beta-Glucans*

Substances

  • Glucans
  • Proteoglycans
  • beta-Glucans
  • polysaccharide-K